OptimizeRx Corporation (OPRX)

Every figure this model derived for OPRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 77,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 24,096,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 54,146,000 AssetsCurrent 2026-06-30
current liabilities 9,711,000 LiabilitiesCurrent 2026-06-30
equity 131,082,000 StockholdersEquity 2026-06-30
interest expense 4,677,000 InterestExpenseNonoperating 2026-06-30
ocf 18,434,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 98,654,000 Revenues 2026-06-30
sbc 7,952,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up OPRX on one particular measure came for.

RatioValue
cash operating margin23.48
current ratio6.01
current ratio reported5.58
deferred revenue growth46.49
dilution pct3.86
fcf margin18.61
growth cv0.63
interest cover2.34
operating margin11.08
owner earnings margin10.55
revenue growth-5.82
revenue growth per share-9.32
roic6.75
rule of 405.26
sbc pct revenue8.06

What to be careful about

What this model itself distrusts about OPRX's figures. Written by the derivation as it ran, not added afterwards.